(Q47771698)

English

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

0 references

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Steinherz PG

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Gaynon PS

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Breneman JC

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Cherlow JM

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Grossman NJ

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Kersey JH

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Johnstone HS

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Sather HN

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Trigg ME

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Uckun FM

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Bleyer WA

11

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

82

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

600-612

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Childhood leukemias

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Analysis of Survival Data under the Proportional Hazards Model

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980201%2982%3A3%3C600%3A%3AAID-CNCR24%3E3.0.CO%3B2-4

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980201)82:3<600::AID-CNCR24>3.0.CO;2-4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9452280

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47771698&oldid=1525891495"